Contact Us

DESTINATION NEWS

Appian Unveils Latest Platform Release for Better Process and Better Outcomes

Dec 4, 2024

New enhancements scale high-volume workflows and increase efficiency and analysis with AI MCLEAN,Va.,Dec. 3,2024-- Appian (Nasdaq: APPN) today announced its latest platform release,which delivers pro

CNEY Receives NASDAQ Minimum Bid Price Requirement Extension

Dec 4, 2024

LISHUI,China,Dec. 4,2024-- CN Energy Group. Inc. (NASDAQ:CNEY) ("CNEY" or the "Company") today announced that on November 26,2024,the Company received a written notice from the Lis

Asia's Transformative Era: Unveiling the "Asian Dream" through New Study "Truth About Ascending Asia"

Dec 4, 2024

SINGAPORE,Dec. 4,2024-- McCann Worldgroup has launched its latest insights study,the Truth about Ascending Asia,at an event held at Singapore\'s Asian Civilisations Museum. Over 70 clients,partners an

KPS CAPITAL PARTNERS TO ACQUIRE COMPOSITES BUSINESS FROM INEOS ENTERPRISES

Dec 4, 2024

A GLOBAL LEADER IN UNSATURATED POLYESTER RESINS, VINYL ESTER RESINS AND GELCOATS NEW YORK,Dec. 3,2024-- KPS Capital Partners,LP ("KPS") announced today that,through a newly formed affiliat

Dahsheng Chemical Launches DURAPONTEX® Grip Insole with Slip-Resistant Technology for Enhanced Athlete Control and Agility

Dec 4, 2024

DURAPONTEX Grip® Innovation Offers a High-Performance Solution for Ultimate Movement Control PORTLAND,Ore.,Dec. 4,2024-- Dahsheng Chemical (DSC®),a leading performance foam manufacturer,annou

Everest Medicines Announces Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of EVER001, a Novel BTK Inhibitor for the Treatment of Primary Membranous Nephropathy

Dec 4, 2024

Patients in the low-dose cohort who have completed 36 weeks of treatment,9 out of 11 (81.8%) achieved overall clinical remission and 10 out of 11 (91%) achieved immunological complete remission.

1 ... 187 188 189 190 191 192 193 ... 351